Anne-Marie
Langevin, MD
- Pediatric Hematology/Oncology
- Pediatrics
If you're an existing patient of Dr. Langevin, please connect via MyChart
Locations
-
-
Pediatric Hematology/Oncology - University Hospital
4502 Medical Drive
San Antonio, TX 78229 -
210-743-2300
-
210-702-6012
-
About Me
Publications
Bartanusz, V., Ziu, M., Jimenez, D. F., Crownover, R. L. & Langevin, A. M. Zoledronic acid therapy for recurrent giant cell tumor of the C2 vertebra in an adolescent. Spine J. 1;15(8):1886-7 (2015). PMID: 25817726
Niece, J.A., Rogers, Z.R., Ahmad, N., Langevin, A.M. & McClain, K.L. Hemophagocytic lymphohistiocytosis in Texas: observations on ethnicity and race. Pediatr Blood Cancer 54(3):424-8 (2010). PMID:19953651
Sugalski, A. J., Jiwani, A., Ketchum, N. S., Cornell, J., Williams, R., Heim-Hall, J., Hung, J. Y. & Langevin, A. M. Characterization of Localized Osteosarcoma of the Extremity in Children, Adolescents, and Young Adults From a Single Institution in South Texas. J. Pediatr. Hematol. Oncol. 36(6):e353-8 (2014). PMID: 24487915; PMCID: PMC4222611
Gender
Female
Languages
English, French, Spanish, Urdu
Credentials
Education
Medical School:
University of Montreal
Residency:
Hospital Maisonneuve Rosemont
Fellowship:
The Hospital for Sick Children
Qualifications
Board Certification:
American Board of Pediatrics/Hematology-Oncology
Treatment and Care
Specific areas of interest and expertise include:
- Blood disorders in children (oncologic-related)
- Bone and soft tissue sarcomas
- Brain and central nervous system tumors
- Cancer predisposition syndromes
- Childhood leukemia
- Childhood lymphoma
- Late effects and survivorship care
- Liver tumors in children
- Neuroblastoma
- Pediatric solid tumors
- Rare childhood cancers
- Retinoblastoma
- Stem cell and bone marrow transplantation
- Supportive cancer care for children
- Wilms tumor and kidney tumors
External Links
-
UT Medicine San Antonio places faculty on top doctors lists
-
UT Medicine physicians recognized as Best Doctors in America®
-
UT Health Science Center to lead regional children’s cancer research group with $3.7 million grant
-
UT Health Science Center San Antonio first U.S. site to offer new immunotherapy cancer trial for children
-
Program to reach out to medically underserved children in South Texas
-
New immunotherapy agent offers hope for kids with cancer
-
Faculty well represented in professional organizations